Ronald Brzana, MD
Gastroenterology · Altoona, PANPI 1861426173
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $857 of the $1,357 with a category attached, or 63.1%. 10 manufacturers reported payments, led by Actuated Medical, Inc. at 36.9% of the total. Reporting peaked in 2021 at $556 and has fallen 84.7% since, to $85 in 2025. That places this record below the midpoint for gastroenterology clinicians in PA, where the typical reported total is $1,806.
Across 46 payments — averaging $29.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actuated Medical, Inc.$500
- AbbVie$497
- Johnson & Johnson$105
- Pfizer$83
- Biofire Diagnostics, LLC$60
- Fujifilm Healthcare Americas Corporation$32
- plus $79 from 4 others
What the payments were for
- Consulting fees$50037%
- Food & beverage$85763%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actuated Medical, Inc. | 1 | $500 |
| AbbVie | 24 | $497 |
| Johnson & Johnson | 8 | $105 |
| Pfizer | 6 | $83 |
| Biofire Diagnostics, LLC | 1 | $60 |
| Fujifilm Healthcare Americas Corporation | 2 | $32 |
| Meridian Bioscience Inc. | 1 | $25 |
| Bristol Myers Squibb | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Axonics, Inc. | 1 | $13 |
How this compares
$1,357 in reported general payments places this provider in the 45th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 17 | $11,053 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 82 | $5,418 |
| Colestipol Hcl | 15 | $1,479 |
| Lansoprazole | 53 | $749 |
| Dicyclomine Hcl | 33 | $683 |
| Famotidine | 40 | $379 |
| Rabeprazole Sodium | 13 | $315 |
| Pantoprazole Sodium | 50 | $244 |
| Ondansetron Hcl | 11 | $195 |
| Omeprazole | 27 | $191 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Altoona
- Mitul PatelAltoona$123K
- Ralph McKibbinAltoona$57K
- Miguel RegueiroPittsburgh$1.5M
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Sandra El-HachemPittsburgh$472K
- Harshit KharaDanville$438K
- Kofi ClarkeHershey$426K
- Michael KochmanPhiladelphia$361K
- Gary LichtensteinPhiladelphia$342K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.